Press
Pharma's biggest losses: Once-dropped drugs make lucrative comebacks
The decision to license or sell a drug depends on profitability, strategic mission, and whether a company “believes” in the science of a drug.
Search
7701 - 7710 out of 10787
Press
Users start innovating for themselves
“Companies need to modify their search process so that they also look for prototype innovations that users have developed for their own needs."
Press
Why do legacy college admissions still exist?
Legacy graduates (and their families) were seven times as likely to make high-dollar donations as non-legacies.
MIT News
An AI Challenge Only Humans Can Solve
In their new book, “Power and Progress,” Daron Acemoglu and Simon Johnson ask whether the benefits of AI will be shared widely or feed inequality.
Press
Have we become too partisan to be swayed? You might be surprised.
"Americans are more receptive to information that challenges their party leader's position than we had previously thought.”
Press
Why our high electric bills might be hurting our climate change goals
Radio Boston talks with MIT's Prof. Chris Knittel about how our high electric bills are hurting our battle against climate change.
Press
From ChatGPT to HackGPT: Meeting the cybersecurity threat of generative AI
“Powerful new generative AI tools such as ChatGPT present business leaders with a new set of challenges.”
Press
Why 'anti-woke' is bad for business
"The party that said it wanted the government to be so small it could be drowned in a bathtub now wants it to be big enough to be everywhere."
Press
5 ways Indian medical administrations can boost hospital cyber-security
"In this article, we provide a list of management action items to boost cybersecurity in hospital environments.”
Press
How did credit market interventions affect macroeconomies during COVID-19?
"The lack of reliable official statistics is a reason that economists haven't tried to quantify the effects of credit policies."